ArticleScientific reports2016

Fucoidan inhibits CCL22 production through NF-κB pathway in M2 macrophages: a potential therapeutic strategy for cancer.

Jia Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.